BD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM

K040099 · Becton, Dickinson & CO · LON · Mar 19, 2004 · Microbiology

Device Facts

Record IDK040099
Device NameBD PHOENIX AUTOMATED MICROBIOLOGY SYSTEM
ApplicantBecton, Dickinson & CO
Product CodeLON · Microbiology
Decision DateMar 19, 2004
DecisionSESE
Submission TypeTraditional
Regulation21 CFR 866.1645
Device ClassClass 2

Indications for Use

The BD Phoenix™ Automated Microbiology System is intended for the rapid identification and in vitro antimicrobial susceptibility testing of isolates from pure culture of most aerobic and facultative anaerobic Gram-negative and Gram-positive bacteria of human origin.

Device Story

BD Phoenix™ Automated Microbiology System performs rapid identification (ID) and antimicrobial susceptibility testing (AST) of bacterial isolates. System components include instrument, software, panels with biochemicals/antimicrobial agents, ID broth, AST broth, and AST indicator solution. BDXpert System, resident on the EpiCenter, provides software-based interpretation of AST results. System uses colorimetric, fluorogenic, and chromogenic substrates for ID; broth microdilution with redox indicator for AST. MIC determined by comparing growth in antibiotic-containing wells versus growth control wells. BDXpert software incorporates specimen type and results from completed antibiotics to infer interpretations for other antibiotics per NCCLS guidelines. Used in clinical microbiology laboratories; operated by laboratory personnel. Output assists clinicians in determining appropriate antimicrobial therapy.

Clinical Evidence

No clinical data provided. Substantial equivalence established via software hazard analysis and adherence to FDA guidance for software in medical devices.

Technological Characteristics

Broth microdilution method using redox indicator for growth detection. System utilizes colorimetric, fluorogenic, and chromogenic substrates. Software-based interpretation via BDXpert System on EpiCenter platform. Complies with NCCLS M7 (M100-S14) standards.

Indications for Use

Indicated for in vitro quantitative determination of antimicrobial susceptibility by MIC of Gram-negative aerobic/facultative anaerobic bacteria (Enterobacteriaceae and Non-Enterobacteriaceae) and Gram-positive bacteria (Staphylococcus and Enterococcus) from pure culture.

Regulatory Classification

Identification

A fully automated short-term incubation cycle antimicrobial susceptibility system is a device that incorporates concentrations of antimicrobial agents into a system for the purpose of determining in vitro susceptibility of bacterial pathogens isolated from clinical specimens. Test results obtained from short-term (less than 16 hours) incubation are used to determine the antimicrobial agent of choice to treat bacterial diseases.

Special Controls

*Classification.* Class II (special controls). The special control for this device is FDA's guidance document entitled “Class II Special Controls Guidance Document: Antimicrobial Susceptibility Test (AST) Systems; Guidance for Industry and FDA.”

Predicate Devices

Submission Summary (Full Text)

{0} 510(k) SUBSTANTIAL EQUIVALENCE DETERMINATION DECISION SUMMARY DEVICE AND INSTRUMENT TEMPLATE A. 510(k) Number: k040099 B. Analyte: Software for the BDXpert System resident on the EpiCenter System C. Type of Test: Software for AST reading and interpretation D. Applicant: Becton, Dickinson and Company E. Proprietary and Established Names: BD Phoenix™ Automated Microbiology System-Modifications to Phoenix™ System Software and for the BDXpert System resident on the EpiCenter System F. Regulatory Information: 1. Regulation section: 866.1645 2. Classification: Class II 3. Product Code: LON 4. Panel: 83 Microbiology G. Intended Use: 1. Intended use(s): The BD Phoenix™ Automated Microbiology System is intended for in vitro quantitative determination of antimicrobial susceptibility by minimal inhibitory concentration of gram-negative aerobic and facultative anaerobic bacteria belonging to the family Enterobacteriaceae and Non-Enterobacteriaceae and gram-positive bacteria belonging to the genera Staphylococcus and Enterococcus. 2. Indication(s) for use: This is for the Modifications to Phoenix™ System Software and for the BDXpert System resident on the EpiCenter System {1} Page 2 of 4 3. Special condition for use statement(s): Prescription Use 4. Special instrument Requirements: Not applicable ## H. Device Description The BD Phoenix™ Automated Microbiology System (Phoenix™ System) is an automated system for the rapid identification (ID) and antimicrobial susceptibility testing (AST) of clinically relevant bacterial isolates. The system includes the following components: BD Phoenix™ instrument and software, BD Phoenix™ Panels containing biochemicals for organism ID testing and antimicrobial agents of AST determinations, BD Phoenix™ ID broth used for performing organism ID testing and preparing AST Broth inoculum, BD Phoenix™ AST Broth used for performing AST tests only, and BD Phoenix™ AST indicator solution added to the AST Broth to aid in bacterial growth determination. ## I. Substantial Equivalence Information: 1. Predicate device name(s): Previously submitted software Phoenix instrumentation such as with gatifloxacin 2. Predicate K number(s): K020321 3. Comparison with predicate: | Similarities | | | | | --- | --- | --- | --- | | Item | Device | | Predicate | | Intended use | The BD Phoenix™ Automated Microbiology System is intended for in vitro quantitative determination of antimicrobial susceptibility by minimal inhibitory concentration of gram-negative aerobic and facultative anaerobic bacteria belonging to the family Enterobacteriaceae and Non-Enterobacteriaceae and gram-positive bacteria belonging to the genera Staphylococcus and Enterococcus | | same | | results | SIR and MIC reported | | same | | | | | | | Differences | | | | | Item | Device | | Predicate | | Test analysis | BDXpert System resident on the EpiCenter does not perform analysis | | Performed by BD Phoenix™ automated Microbiology System | | Use of additional | Uses specimen type in | | Does not use this | {2} Page 3 of 4 | information | determining interpretation | information | | --- | --- | --- | | Resistant marker feature | Uses results from completed antibiotics to infer interpretations on other antibiotics when applicable (as recommended by NCCLS etc.) | All results are read at the completed time for each antibiotic | J. Standard/Guidance Document Referenced (if applicable): NCCLS M7 (M100-S14) “Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically; Approved Standard” and the “Guidance for the Content of PreMarket Submissions for Software in Medical Devices”. K. Test Principle: The system employs conventional, colorimetric, fluorogenic and chromogenic substrates to identify the genus and species of the isolate. The AST portion of the Phoenix™ System is a broth based microdilution method that utilizes a redox indicator (colorimetric oxidation-reduction) to enhance detection of organism growth. The MIC is determined by comparing growth in wells containing serial two-fold dilutions of an antibiotic to the growth in “growth control wells” which contain no antibiotic. L. Performance Characteristics (if/when applicable): 1. Analytical performance: a. Precision/Reproducibility: Not applicable b. Linearity/assay reportable range: Not applicable c. Traceability (controls, calibrators, or method): Not applicable d. Detection limit: Not applicable e. Analytical specificity: Not applicable f. Assay cut-off: Not applicable 2. Comparison studies: a. Method comparison with predicate device: Not applicable b. Matrix comparison: Not applicable 3. Clinical studies: a. Clinical sensitivity: Not applicable {3} Page 4 of 4 b. Clinical specificity: Not applicable c. Other clinical supportive data (when a and b are not applicable): Not applicable 4. Clinical cut-off: Not applicable 5. Expected values/Reference range: Not applicable **M. Instrument Name:** BD Phoenix™ Automated Microbiology System **N. System Descriptions:** 1. Modes of Operation: Not Applicable 2. Software: FDA has reviewed applicant’s Hazard Analysis and software development processes for this line of product types: Yes ☐ X ☐ or No ☐ 3. Sample Identification: Not applicable 4. Specimen Sampling and Handling: Not applicable 5. Assay Types: Not applicable 6. Reaction Types: Not applicable 7. Calibration: Not applicable 8. Quality Control: Not applicable **O. Other Supportive Instrument Performance Characteristics Data Not Covered In The “L. Performance Characteristics” Section Of the SE Determination Decision Summary.** Not applicable **P. Conclusion:** The information contained within this submission is sufficient to meet the software concerns as described in the Guidance for the Content of Premarket Submissions for Software Contained in Medical Devices, and it is recommended that, from a software standpoint, this device be considered substantially equivalent.
Innolitics

Panel 1

/
Ready

Predicate graph will load when search results are available.

Embedding visualization will load when search results are available.

PDF viewer will load when search results are available.

Loading panels...

Select an item from Submissions

Click any panel, subpart, regulation, product code, or device to see details here.

Section Matches

Results will appear here.

Product Code Matches

Results will appear here.

Special Control Matches

Results will appear here.

Loading collections...